Gastric Sleeve vs Weight-Loss Injections: How They Compare
Key takeaways
- A gastric sleeve is a permanent operation that removes about 70 to 80% of the stomach; weight-loss injections are an ongoing medicine you keep taking.
- The sleeve typically loses about 60 to 70% of excess weight over 12 to 18 months; semaglutide trials average around 15% of total body weight and tirzepatide around 20%.
- Injections avoid surgery and its risks, but weight tends to return when you stop, whereas the sleeve is a one-off operation with its own real risks, including reflux.
- Both are tools, not cures: each works only alongside lasting changes to how you eat, and the right choice is an individual decision with your medical team.
The main difference is permanence: a gastric sleeve is a one-off operation that removes about 70 to 80% of the stomach, while weight-loss injections are an ongoing medicine you keep taking, and weight tends to return if you stop. Both are real, evidence-based treatments for obesity, and neither is a quick fix. This guide compares them fairly so you can weigh them up with your own team.
When I was deciding, the injections most people now ask about were not yet widely available, so I weighed surgery against dieting. If I were starting today, I would still want to understand exactly how each option works, and what happens long-term, before choosing. Here is that picture, side by side.
How each one works
The two routes change your appetite in very different ways.
A gastric sleeve (sleeve gastrectomy) physically removes the larger, curved part of the stomach, leaving a narrow sleeve. It works by restriction (a much smaller stomach that fills fast) and a hormonal effect: removing that part of the stomach lowers ghrelin, the main hunger hormone. You can read the full mechanism in how the gastric sleeve works.
Weight-loss injections are GLP-1 receptor agonists: semaglutide (Wegovy) and the dual GLP-1/GIP medicine tirzepatide (Mounjaro). They mimic gut hormones that slow stomach emptying and signal fullness to the brain, so you feel satisfied on less food. They are usually a once-weekly injection that you continue taking, with the dose stepped up gradually.
How much weight you lose
On average the sleeve still produces the larger loss. After a sleeve, most people lose about 60 to 70% of their excess weight over 12 to 18 months, which for many is roughly a quarter to a third of total body weight. In clinical trials, semaglutide averaged around 15% of total body weight and tirzepatide around 20%, both alongside diet and activity. Results vary widely with every option, and they depend heavily on the changes you make to how you eat.
Permanence and weight regain
This is the sharpest contrast. The sleeve is irreversible: the removed stomach is gone, so its effect does not switch off. Injections work only while you take them; trials show that when people stop a GLP-1 medicine, much of the lost weight returns over the following year as appetite rebounds. That makes the medicines long-term treatment rather than a short course.
Neither route is regain-proof, though. Weight can creep back after a sleeve too if old habits return, which is covered in gastric sleeve weight regain. The honest framing for both is the same: they make eating less far easier, but the habits do the long-term work.
Side effects and risks
The risks are different in kind. Injections most commonly cause nausea, vomiting, diarrhoea, and constipation, usually worst as the dose rises, and they are stopped in some people because of this. Surgery carries operative risks instead: a staple-line leak (about 1% or under), bleeding, blood clots, narrowing, and reflux, with a low mortality of roughly 0.1 to 0.3%. Reflux is a sleeve-specific issue worth understanding in gastric sleeve and reflux. Both can leave nutritional gaps that need monitoring.
Cost over time
Cost is not just a single number; it is a number over time. A private sleeve in the UK is roughly £8,000 to £12,000 as a one-off (US self-pay is about $15,000 to $25,000). Injections are a monthly cost that continues for as long as you take them, so over several years the running total can match or exceed the price of surgery. The NHS or insurance may fund either when eligibility criteria are met. The trade-off is one upfront expense against an indefinite ongoing one.
Which might suit you
There is no single right answer; it depends on your health, your BMI, and how you feel about surgery. Injections can suit people who want to avoid an operation or are not yet sure about a permanent change, while the sleeve can suit people seeking a one-off intervention with larger average loss. Eligibility, comorbidities, and your own preferences all matter. Our piece on whether the gastric sleeve is worth it and the comparison with diet and exercise may help you frame the decision.
The single most useful thing I learned is that these are tools, not cures. Whichever you choose, the weight that stays off is the part you keep working at.
This guide is general information, not a diagnosis or a recommendation, and not individual medical advice. Decisions about surgery or weight-loss medication should be made with a GP or a qualified bariatric team who can assess you individually.
References
- Weight loss surgery, NHS.
- Semaglutide for managing overweight and obesity (TA875), NICE.
- Tirzepatide for managing overweight and obesity (TA1026), NICE.
- Sleeve gastrectomy, Mayo Clinic.
Frequently asked questions
Is the gastric sleeve better than weight-loss injections?
Neither is simply better: they suit different people. The sleeve is a one-off operation that typically loses about 60 to 70% of excess weight over 12 to 18 months and does not depend on staying on a medicine. Injections such as semaglutide (around 15% of total body weight) or tirzepatide (around 20%) avoid surgery, but you keep taking them and weight usually returns if you stop. The right choice is an individual decision made with your medical team.
Do you lose more weight with surgery or injections?
On average the sleeve still produces more weight loss. People lose about 60 to 70% of their excess weight after a sleeve, which is often roughly a quarter to a third of total body weight. In trials, semaglutide (Wegovy) averaged about 15% of total body weight and tirzepatide (Mounjaro) about 20%, though individual results vary widely with both routes.
Will I regain the weight if I stop the injections?
Usually yes, at least in part. Studies show that when people stop a GLP-1 medicine, appetite returns and much of the lost weight comes back over the following year, because the drug is no longer suppressing hunger. That is why these medicines are framed as long-term treatment. The sleeve is permanent, but it is not regain-proof either: weight can creep back if eating habits drift.
Which is cheaper, a gastric sleeve or weight-loss injections?
It depends on how long you stay on the medicine. A private sleeve in the UK is roughly £8,000 to £12,000 as a one-off (US self-pay is about $15,000 to $25,000). Injections are a monthly cost that continues indefinitely, so over several years the running total can match or exceed the cost of surgery. Both may be funded by the NHS or insurance when eligibility criteria are met.
Can you take weight-loss injections after a gastric sleeve?
Sometimes, yes. A GLP-1 medicine is occasionally used alongside or after surgery, for example if weight comes back or loss stalls, but only when a bariatric or specialist team prescribes and monitors it. This is an individual clinical decision, not something to start on your own; talk it through with the team who looks after you.
What are the side effects of each?
Injections most often cause nausea, vomiting, diarrhoea, and constipation, usually worst when the dose goes up. The sleeve carries surgical risks instead: a staple-line leak (about 1% or under), bleeding, blood clots, narrowing, and reflux, with a low mortality of roughly 0.1 to 0.3%. Both can lead to nutritional gaps that need monitoring.
Written by Claire Maddox. Medically reviewed by Mr Ian Calloway, MBBS, FRCS.
Our guides are written from personal experience and reviewed by a qualified clinician for accuracy. Read our editorial policy.